XPHYF News and Press, XPhyto Therapeutics Corp From 03/04/21

VANCOUVER, BC / ACCESSWIRE / March 4, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company"), is pleased to announce that the Company has completed a corporate rebranding and launched a new website which can be viewed at www.xphyto.com . The rebrand...

V ANCOUVER, BC / ACCESSWIRE / February 26, 2021 / XPhyto Therapeutics Corp. ( CSE :XPHY)(OTCQB:XPHYF)(FSE:4XT ) (" XPhyto" or the " Company ") at the request of IIROC and the Canadian Securities Exchange (the " CSE ") is providing additional comments to its news release and list of thir...

ORLANDO, Fla., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Today, we are pleased to introduce a new featured company, and one that is making news in the battle against COVID-19 due to recent achievements for the Company’s technology in the critical diagnostic market. XPhyto Therapeutic...

VANCOUVER, BC / ACCESSWIRE / February 24, 2021 / XPhyto Therapeutics Corp . ( CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (" XPhyto " or the " Company "), is pleased to announce that it has placed the first order for its rapid point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system ("Covid-ID Lab") f...

VANCOUVER, BC / ACCESSWIRE / February 22, 2021 / XPhyto Therapeutics Corp . ( CSE:XPHY / OTCQB:XPHYF / FSE:4XT ) (" XPhyto " or the " Company "), is pleased to announce that the Company has expedited the formation of an experienced commercial team to launch its point-of-care SARS-CoV-2 (C...

VANCOUVER, BC / ACCESSWIRE / February 19, 2021 / XPhyto Therapeutics Corp . ( CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (" XPhyto " or the " Corporation ") is providing the following comments regarding a claim made against Vektor Pharma TF GMBH ("Vektor"), one of the Corporation's German subsidi...

VANCOUVER, BC / ACCESSWIRE / February 16, 2021 / XPhyto Therapeutics Corp . ( CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (" XPhyto " or the " Company "), and its exclusive German diagnostics development partner, 3a-diagnostics GmbH ("3a"), are pleased to announce that all actions and procedures req...

VANCOUVER, BC / ACCESSWIRE / February 10, 2021 / XPhyto Therapeutics Corp . ( CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (" XPhyto " or the " Company ") is pleased to announce that XPhyto Laboratories Inc., its wholly owned Alberta subsidiary, has added mescaline production to its psychedelic medic...

VANCOUVER, BC / ACCESSWIRE / February 3, 2021 / XPhyto Therapeutics Corp . ( CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (" XPhyto " or the " Company ") is pleased to announce that XPhyto Laboratories Inc. ("XPhyto Labs"), its wholly owned Alberta subsidiary, has signed an agreement (the "Agreement"...

Construction of commercial drug manufacturing facility in Germany Four clinical studies in neurological indications in 2021 Development of oral biosensor and contract development & manufacturing Psychedelic transdermal and sublingual drug formulation development VANC...